Clinical Trial Update: Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of pembrolizumab with radiotherapy for extranodal NK/T-cell lymphoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Lymphoma, Extranodal NK-T-Cell | Phase 2 | Status: ACTIVE_NOT_RECRUITING